Drug Availability

HPS Pharmacies wish to give notice that all suppliers are experiencing a supply interruption for all strengths of levothyroxine sodium tablets as follows:

Product ARTG Expected Return Date
Eltroxin® 25mcg 206944 Early May 2020*
Eltroxin® 50mcg 206960 Early May 2020
Eltroxin® 75mcg 206961 Late April 2020
Eltroxin® 100mcg 206963 Early April 2020*
Eltroxin® 125mcg 206974 Late April 2020*
Eltroxin® 200mcg 206954 Early April 2020
Eutroxsig® 50mcg 125501 Mid April 2020
Eutroxsig® 75mcg 144117 Mid April 2020
Eutroxsig® 100mcg 125502 Late April 2020
Eutroxsig® 200mcg 125503 Late April-early May 2020
Oroxine® 50mcg 125498 End April 2020
Oroxine® 75mcg 144108 Late April 2020
Oroxine® 100mcg 125499 Mid-late April 2020
Oroxine® 200mcg 125500 Mid-late April 2020

*Warehouses still have limited stock in some states

These supply interruptions are due to an unexpected increase in demand. Eutroxsig® and Oroxine® are not bioequivalent to Eltroxin®. If it is considered necessary to change to or from Eltroxin®, thyroid function should be monitored and the dose adjusted accordingly.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates